Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Alzheimer's Disease

Free Subscription 13.07.2026 1 Acta Neuropathol 1 Alzheimer Dis Assoc Disord 9 Alzheimers Dement 1 Am J Epidemiol 1 Biochemistry (Mosc) 1 BMC Neurol 4 Brain 2 Brain Res 2 Curr Alzheimer Res 1 Dement Geriatr Cogn Disord 11 J Alzheimers Dis 1 JAMA 3 Nat Neurosci 1 Neurobiol Aging 1 Neurobiol Dis 2 Neurochem Res 1 Neurology 1 Neurosci Lett 3 PLoS One 1 Proc Natl Acad Sci U S A 1 Science

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Neuropathol

1. RANA JK, Pinarbasi ES, Fernandez MG, Navratna V, et al
   CTE-type tau filaments in Alzheimer's disease with co-morbid LATE-NC.
   Acta Neuropathol. 2026;152:3.
   PubMed        
   
   

   
   Alzheimer Dis Assoc Disord

2. NAKAMURA Y, Tsushio T, Tanahashi M, Suganami H, et al
   Post Hoc Subgroup Analysis by Disease Severity in a Non-Inferiority Trial of Donepezil 27.5 mg Transdermal Formulation in Japanese Patients With Mild-to-Moderate Alzheimer Disease.
   Alzheimer Dis Assoc Disord. 2026 Jul 6. doi: 10.1097/WAD.0000000000000738.
   PubMed         Abstract available
   
   

   
   Alzheimers Dement

3. STOCKS J, Barbieri E, Los MA, Thompson CK, et al
   Neuropathology-specific language features in primary progressive aphasia.
   Alzheimers Dement. 2026;22:e71633.
   PubMed         Abstract available
   
   
4. LORENZ AS, Sathe A, Yang Y, Durant A, et al
   Genetic architecture of the limbic white matter microstructure in aging and Alzheimer's Disease.
   Alzheimers Dement. 2026;22:e71630.
   PubMed         Abstract available
   
   
5. ANAGNOSTAKIS F, O'Toole CK, Erus G, Srinivasan D, et al
   Association of sleep duration with Alzheimer's disease and cognition.
   Alzheimers Dement. 2026;22:e71528.
   PubMed         Abstract available
   
   
6. YANG Y, Lorenz A, Sathe A, Schilling KG, et al
   Genetically linked brain imaging markers of memory decline in aging and Alzheimer's disease.
   Alzheimers Dement. 2026;22:e71663.
   PubMed         Abstract available
   
   
7. BEVINS EA, Leger GC, Herman MA, Ringman JM, et al
   Safety considerations of gene-based therapies for Alzheimer's disease.
   Alzheimers Dement. 2026;22:e71515.
   PubMed         Abstract available
   
   
8. KHANDELWAL P, Duong MT, Levorse LM, Trotman W, et al
   Postmortem brain MRI reveals differential associations of subcortical and limbic volumes with cortical thinning and neurodegenerative pathologies.
   Alzheimers Dement. 2026;22:e71649.
   PubMed         Abstract available
   
   
9. MOGHEKAR AR, Rock JA, Mohs RC, Hansson O, et al
   Multicenter validation of plasma p-tau217/ amyloid beta 1-42 ratio in symptomatic Alzheimer's disease.
   Alzheimers Dement. 2026;22:e71644.
   PubMed         Abstract available
   
   
10. HIRSCH F, Frontzkowski L, Steward A, Roemer-Cassiano SN, et al
    Modular brain networks shape amyloid-driven tau spread and cognitive decline.
    Alzheimers Dement. 2026;22:e71617.
    PubMed         Abstract available
    
    
11. CAI Y, Wang Y, Huang W, Su Y, et al
    Lecanemab treatment improves B cell subpopulation immune homeostasis in patients with Alzheimer's disease.
    Alzheimers Dement. 2026;22:e71655.
    PubMed         Abstract available
    
    

    
    Am J Epidemiol

12. MOCK L, Mork D, Audirac M, Braun D, et al
    Hospitalization risk with and without dementia by region and race in the United States.
    Am J Epidemiol. 2026;195:1839-1849.
    PubMed         Abstract available
    
    

    
    Biochemistry (Mosc)

13. BLAGOVA AV, Perepelitsa ES, Satish A, Lifanov DA, et al
    Development of Metabolic Stress in Vascular Organoids under Normal Conditions and with AD/PD-Associated Genetic Backgrounds.
    Biochemistry (Mosc). 2026;91:992-1005.
    PubMed         Abstract available
    
    

    
    BMC Neurol

14. KASUGA K, Shimizu S, Kimura N, Kasanuki K, et al
    Diagnostic delay in early-onset Alzheimer's disease in Japan: a retrospective study.
    BMC Neurol. 2026 Jul 9. doi: 10.1186/s12883-026-05121.
    PubMed         Abstract available
    
    

    
    Brain

15. BANERJEE G, van Veluw SJ
    Untangling the web of APOE, cerebral amyloid angiopathy and Alzheimer's disease.
    Brain. 2026 Jul 10:awag243. doi: 10.1093.
    PubMed        
    
    
16. PELKMANS W, Bikou V, Salvado G
    Timing the Alzheimer's disease pathological cascade.
    Brain. 2026 Jul 8:awag240. doi: 10.1093.
    PubMed        
    
    
17. TUNG TH, Babu S, Tang X, Sciutto AL, et al
    Fus-depleted oligodendrocytes reduce neuronal damage and Alzheimer's disease progression in the AppNL-G-F mouse.
    Brain. 2026 Jul 6:awag234. doi: 10.1093.
    PubMed         Abstract available
    
    
18. LIU N, Yang Y, Kritsilis M, Swanberg KM, et al
    Early glymphatic failure in AppNL-F knock-in mice is linked to parenchymal border macrophages loss.
    Brain. 2026;149:2422-2437.
    PubMed         Abstract available
    
    

    
    Brain Res

19. TOYOKAWA M, Yasuda K, Kikuya A, Asada-Utsugi M, et al
    Amyloid-beta1-42 oligomers compromise oligodendrocyte precursor cells and disrupt blood-brain barrier integrity in vitro.
    Brain Res. 2026;1888:150436.
    PubMed         Abstract available
    
    
20. HOUMAM S, Siodlak D, Seshadri M, Hallum GB, et al
    Cell-specific expression of APP and GABA(B)R1 isoforms in wild-type and the APP NL-G-F mouse model of Alzheimer's disease.
    Brain Res. 2026 Jul 9:150463. doi: 10.1016/j.brainres.2026.150463.
    PubMed         Abstract available
    
    

    
    Curr Alzheimer Res

21. HU Z, Su Y, Xi J, Li J, et al
    Diagnostic Accuracy of Plasma p-tau181 Measured Using Automated Chemiluminescent Immunoassays for Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    Curr Alzheimer Res. 2026 Jul 6. doi: 10.2174/0115672050477953260623073513.
    PubMed         Abstract available
    
    
22. AFOLABI BL, Ajibola AA, Adeyanju AA, Akanji MA, et al
    Revisiting Alzheimer's Disease Mechanisms: Amyloid Dynamics, and Emerging Insights.
    Curr Alzheimer Res. 2026 Jul 3. doi: 10.2174/0115672050395410251029173713.
    PubMed         Abstract available
    
    

    
    Dement Geriatr Cogn Disord

23. RODGERS FE, Huntley J, McWilliams A, Sommerlad A, et al
    Theory of mind deficits and awareness in Alzheimer's disease.
    Dement Geriatr Cogn Disord. 2026 Jul 7:1-14. doi: 10.1159/000553343.
    PubMed         Abstract available
    
    

    
    J Alzheimers Dis

24. GHAEDRAHMAT Z, Almasi F, Shamsi Goushki J, Moghiseh Z, et al
    The role of organochlorine pesticides as environmental factors in Alzheimer's disease in human studies: A systematic review and meta-analysis.
    J Alzheimers Dis. 2026 Jul 7:13872877261465828. doi: 10.1177/13872877261465828.
    PubMed         Abstract available
    
    
25. WANG MT, Zhao RC, Huang M, Chen J, et al
    Plasma profiling of B lymphocyte-associated cytokines in Alzheimer's disease.
    J Alzheimers Dis. 2026 Jul 7:13872877261464184. doi: 10.1177/13872877261464184.
    PubMed         Abstract available
    
    
26. DAY SM, Reitz NL, Savage LM
    Adolescent intermittent ethanol exacerbates amyloid-beta with age in the dorsal hippocampus of female TgF344-AD rats.
    J Alzheimers Dis. 2026;112:861-874.
    PubMed         Abstract available
    
    
27. LI D, Dai W, Li X, Li H, et al
    Amyloid-beta suppresses oligodendrocyte differentiation in adult oligodendrocyte precursor cells (OPCs), with inflammatory gene changes distinguishing it from developmental OPCs.
    J Alzheimers Dis. 2026;112:852-860.
    PubMed         Abstract available
    
    
28. CLUTE-REINIG N, Helfman S, Lakis J, Epstein L, et al
    Attitudes toward preventive neurology care: A cross-sectional survey study.
    J Alzheimers Dis. 2026;112:690-702.
    PubMed         Abstract available
    
    
29. LIU M, Li X, Fang H, Miao D, et al
    Development and validation of a novel single molecular immunology assay for detection of p-Tau181.
    J Alzheimers Dis. 2026;112:797-805.
    PubMed         Abstract available
    
    
30. SHI Y, Ci R, Geng C, Zhang X, et al
    Disruptions of the diffusion tensor image analysis along the perivascular space index and dynamic functional connectivity across the Alzheimer's disease spectrum: Implications for cognitive impairment.
    J Alzheimers Dis. 2026 Jul 7:13872877261465700. doi: 10.1177/13872877261465700.
    PubMed         Abstract available
    
    
31. DIMAS-HARMS LJ, Moser VA
    The arsenic-Alzheimer's disease link: Emerging evidence and unanswered questions.
    J Alzheimers Dis. 2026 Jul 8:13872877261467042. doi: 10.1177/13872877261467042.
    PubMed         Abstract available
    
    
32. BEN-HAYUN R, Zifman N, Hadad R, Fogel H, et al
    Towards a neurophysiological diagnostic marker of Alzheimer's disease using transcranial magnetic stimulation combined with electroencephalography.
    J Alzheimers Dis. 2026 Jul 8:13872877261463653. doi: 10.1177/13872877261463653.
    PubMed         Abstract available
    
    
33. SOLFRIZZI V, Imbimbo BP
    Frailty as an underrepresented dimension in clinical trials of Alzheimer's disease therapies.
    J Alzheimers Dis. 2026 Jul 9:13872877261466693. doi: 10.1177/13872877261466693.
    PubMed         Abstract available
    
    
34. LU K, Lu Y, Tang R, Dong X, et al
    Mechanisms of autophagy-lysosome pathway impairment in Alzheimer's disease.
    J Alzheimers Dis. 2026 Jul 10:13872877261460879. doi: 10.1177/13872877261460879.
    PubMed         Abstract available
    
    

    
    JAMA

35. LYNDON S, Behlke LM, Urizar JC, Daffner KR, et al
    Alzheimer Disease Biomarkers and Assisted Dying: When Diagnosis Becomes a Deadline.
    JAMA. 2026 Jul 9. doi: 10.1001/jama.2026.11317.
    PubMed        
    
    

    
    Nat Neurosci

36. WISEMAN S
    Glycosylation in Alzheimer's disease.
    Nat Neurosci. 2026;29:1528.
    PubMed        
    
    
37. D'OLEIRE UQUILLAS F, Sefik E, Seidlitz J, Daniel Hertz E, et al
    Cerebellar aging is spatially heterogeneous and supports cognitive resilience in later life.
    Nat Neurosci. 2026;29:1699-1710.
    PubMed         Abstract available
    
    
38. LIU W, Wu SA, Zhang BX, Guo SH, et al
    Tau aggregates cause reactivation of transposable DNA elements, leading to Z-RNA-ZBP1-mediated neuronal death.
    Nat Neurosci. 2026;29:1559-1572.
    PubMed         Abstract available
    
    

    
    Neurobiol Aging

39. PEGORARO G, MacBean LF, Smith AR, Soanes DM, et al
    Systemic infections alter cortical transcriptional signatures in Alzheimer's disease.
    Neurobiol Aging. 2026;167:155-167.
    PubMed         Abstract available
    
    

    
    Neurobiol Dis

40. AVILA-GUTIERREZ K, de Sauvage MAC, Depret N, Oudart M, et al
    Local translation controls early reactive changes in perisynaptic astrocyte processes at pre-symptomatic stages of Alzheimer's disease.
    Neurobiol Dis. 2026 Jul 9:107528. doi: 10.1016/j.nbd.2026.107528.
    PubMed         Abstract available
    
    

    
    Neurochem Res

41. SUO X, Wan P, Yu J, Zhu X, et al
    The Protective Effects of Small-Molecule Compound 0242 Against LPS-Induced Neuroinflammation and in P301S Tau Transgenic Mice.
    Neurochem Res. 2026;51:209.
    PubMed         Abstract available
    
    
42. LIU Y, Li M, Yu H, Liu H, et al
    Regulatory Effects of the PDE8B Inhibitor PF-04957325 on Cognitive Impairment and Neuroinflammation in Abeta-Induced Alzheimer's Disease Mouse Models.
    Neurochem Res. 2026;51:210.
    PubMed         Abstract available
    
    

    
    Neurology

43. KIVISILD A, Aaltonen M, Aho K, Heikkinen SV, et al
    Long-Term Income and Productivity Losses in Individuals With Early-Onset Dementia: Evidence From 15 Years Preceding the Diagnosis.
    Neurology. 2026;107:e218268.
    PubMed         Abstract available
    
    

    
    Neurosci Lett

44. FRITZ N, Johannesson M, Eriksson F, Osswald G, et al
    Lecanemab promotes Fc receptor-dependent cell-mediated internalization and degradation of aggregated amyloid-beta in vitro and ex vivo.
    Neurosci Lett. 2026;882:138645.
    PubMed         Abstract available
    
    

    
    PLoS One

45. MIAO L, Hou F, Li G
    Key targets and mechanisms by which gut microbiota-derived metabolites regulate Alzheimer's disease through the immune - inflammatory pathway: Based on network pharmacology and molecular docking.
    PLoS One. 2026;21:e0352999.
    PubMed         Abstract available
    
    
46. NASIR AB, Kilani Y, Aldiabat M, Abdelghany O, et al
    Metabolic risk and metabolic dysfunction-associated steatotic liver disease and steatohepatitis in cognitive decline: A retrospective cohort study.
    PLoS One. 2026;21:e0353160.
    PubMed         Abstract available
    
    
47. O'SHEA DM, Chang LC, Chowdhury M, Cook DJ, et al
    The heat exposure, aging trajectories, and Alzheimer's disease (HEAT-AD) study protocol.
    PLoS One. 2026;21:e0350611.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

48. BAHRI S, Palani RS, Silvers R, Michael B, et al
    High-resolution structure of monomorphic Abeta(1-40) fibrils.
    Proc Natl Acad Sci U S A. 2026;123:e2603575123.
    PubMed         Abstract available
    
    

    
    Science

49. CROWLEY G, Kim M, O'Neill N, Turkes E, et al
    C1q and immunoglobulins mediate activity-dependent synapse loss in the adult brain.
    Science. 2026;393:eadv1219.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum